Infinity Pharmaceuticals, Inc.
(NASDAQ : INFI)

( )
INFI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -6.73%146.810.0%$1534.10m
OCGNOcugen, Inc. -4.19%9.600.0%$1069.86m
NVAXNovavax, Inc. -14.27%205.9992.9%$909.19m
AMGNAmgen, Inc. -0.60%225.691.3%$548.32m
VRTXVertex Pharmaceuticals, Inc. 0.80%212.061.9%$521.91m
REGNRegeneron Pharmaceuticals, Inc. -1.77%454.862.7%$509.91m
ILMNIllumina, Inc. -1.23%441.013.5%$504.66m
GILDGilead Sciences, Inc. 0.88%63.011.0%$479.35m
ALXNAlexion Pharmaceuticals, Inc. -1.05%150.372.0%$354.39m
BNGOBionano Genomics, Inc. -3.66%9.480.0%$340.06m
BIIBBiogen, Inc. -1.24%269.851.7%$329.36m
CRSPCRISPR Therapeutics AG -0.37%129.770.6%$302.39m
EXASEXACT Sciences Corp. -2.72%136.3918.4%$253.67m
SGENSeagen Inc. 0.76%153.715.8%$214.53m
VXRTVaxart, Inc. -5.43%7.140.0%$189.51m

Company Profile

Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.